SCHEMBL4757597

SCHEMBL4757597

CC(=O)NCC(=O)N1CCC(C=O)CC1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FAP Q12884 2/20 0.44
DPP4 P27487 1/20 0.44
PREP P48147 1/20 0.44
ALDH1A1 P00352 6/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 1/20 0.38
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
NPSR1 Q6W5P4 1/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 2/20 0.36
TGM2 P21980 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
TLR8 Q9NR97 1/20 0.35
TLR7 Q9NYK1 1/20 0.35
ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23199283 0.85 SMN1; SMN2 (0.40) ALDH1A1KMT2AMEN1TSHRSMN1; SMN2
SCHEMBL12436977 0.79 FAP (0.46) FAPDPP4PREPALDH1A1KMT2A
SCHEMBL14115757 0.79 GNAI3 (0.49) FAPDPP4PREPALDH1A1KMT2A
SCHEMBL23173665 0.79 MEN1 (0.63) ALDH1A1KMT2AMEN1TSHRKDM4E
SCHEMBL8342117 0.78 FAP (0.45) FAPDPP4PREPALDH1A1KMT2A
SCHEMBL24272052 0.78 L3MBTL1 (0.47) FAPDPP4PREPALDH1A1KMT2A
SCHEMBL22919353 0.77 EPHX2 (0.49) ALDH1A1NPC1
SCHEMBL17642627 0.77 FAP (0.44) FAPDPP4PREPALDH1A1KMT2A
SCHEMBL10274507 0.77 L3MBTL3 (0.46) FAPDPP4PREPALDH1A1KMT2A
SCHEMBL4757596 0.77 FAP (0.44) FAPDPP4PREPALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008133344-A2 PIPERIDINE DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-11-06 WO claimed
US-20080275085-A1 Piperidine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-11-06 US claimed
WO-2008133344-A2 PIPERIDINE DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-11-06 WO disclosed
US-20080275085-A1 Piperidine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275085-A1 Piperidine derivative and use thereof TACR2, TACR1, PRLHR FAP 3998/4885DPP4 1785/4885PREP 909/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.